0001562180-20-006656.txt : 20201110 0001562180-20-006656.hdr.sgml : 20201110 20201110180058 ACCESSION NUMBER: 0001562180-20-006656 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201106 FILED AS OF DATE: 20201110 DATE AS OF CHANGE: 20201110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEER RANDOLPH C CENTRAL INDEX KEY: 0001198762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 201302399 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-11-06 false 0000842023 BIO-TECHNE Corp TECH 0001198762 STEER RANDOLPH C 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 true false false false Common Stock 2020-11-06 4 M false 5000.00 70.35 A 10112.00 D Common Stock 2020-11-06 4 M false 5000.00 66.90 A 15112.00 D Common Stock 2020-11-06 4 S false 1723.00 299.06 D 13389.00 D Common Stock 2020-11-06 4 S false 1771.00 299.96 D 11618.00 D Common Stock 2020-11-06 4 S false 1801.00 301.78 D 9817.00 D Common Stock 2020-11-06 4 S false 1195.00 302.31 D 8622.00 D Common Stock 2020-11-06 4 S false 975.00 304.14 D 7647.00 D Common Stock 2020-11-06 4 S false 2535.00 304.59 D 5112.00 D Stock Option (Right to Buy) 70.35 2020-11-06 4 M false 5000.00 0.00 D 2011-10-27 2021-10-26 Common Stock 5000.00 0.00 D Stock Option (Right to Buy) 66.90 2020-11-06 4 M false 5000.00 0.00 D 2012-10-25 2022-10-24 Common Stock 5000.00 0.00 D Stock Option (Right to Buy) 255.69 2021-10-29 2030-10-29 Common Stock 1507.00 1507.00 D Stock Option (Right to Buy) 201.64 2020-10-24 2029-10-24 Common Stock 2011.00 2011.00 D Stock Option (Right to Buy) 179.84 2019-10-24 2028-10-25 Common Stock 1898.00 1898.00 D Stock Option (Right to Buy) 125.05 2018-10-25 2027-10-26 Common Stock 3125.00 3125.00 D Stock Option (Right to Buy) 101.19 2017-10-26 2026-10-26 Common Stock 3985.00 3985.00 D Stock Option (Right to Buy) 87.34 2016-10-29 2025-10-28 Common Stock 4260.00 4260.00 D Stock Option (Right to Buy) 91.78 2014-10-30 2024-10-30 Common Stock 4000.00 4000.00 D Stock Option (Right to Buy) 87.39 2013-10-31 2023-10-30 Common Stock 4000.00 4000.00 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.49 to $299.30, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.70 to $300.42, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.98, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.67, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.47 to $304.46, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.59 to $304.67, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Brenda S. Furlow, attorney in fact for Randolph C. Steer pursuant to Power of Attorney previously filed 2020-11-10